For the quarter ending 2026-03-31, BNBX made $1,024,111 in revenue. -$6,665,227 in net income. Net profit margin of -650.83%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Total revenues | 1,024,111 | 565,394 | 534,233.75* | |
| Cost of product revenues | 197,325 | 250,037 | 324,507* | |
| Gross profit | 826,786 | 315,357 | 209,726.75* | |
| Selling, general and administrative | 2,591,647 | 13,348,510 | 2,717,147.5* | |
| Realized gain on derivative written call options | 21,573 | - | - | |
| Loss from change in fair value of digital assets | -2,086,347 | -1,732,557 | - | |
| Loss from fair value measurement of investment in digital asset trust | -2,548,799 | -3,484,009 | - | |
| Research and development | 372,149 | 458,562 | 1,504,228* | |
| Total operating expenses | 7,577,369 | 19,023,638 | 4,221,375.5* | |
| Loss from operations | -6,750,583 | -18,708,281 | -4,011,648.75* | |
| Interest income | 3,761 | 9,143 | 48,228.75* | |
| Unrealized gain on change in fair value of warrants classified as a liability | - | -370 | -79,907.5* | |
| Other income (expense), net | 81,663 | 92,586 | -26,645* | |
| Loss before provision for income taxes | -6,665,159 | -18,606,182 | -3,910,157.5* | |
| Income tax provision benefit | - | - | -171,028.75* | |
| Net loss from continuing operations | -6,665,159 | -18,606,182 | -3,739,128.75* | |
| Clinical laboratory service revenues | - | - | 143,232* | |
| Cost of clinical laboratory service revenues | - | - | 197,613.75* | |
| Gross profit | - | - | -54,381.75* | |
| Selling, general and administrative | - | - | 53,776.25* | |
| Interest (income) | - | - | 825.25* | |
| Other expense, net | - | - | 9,150* | |
| Net loss from discontinued operations | - | - | -98,182.75 | |
| Net loss from discontinued operations, net of tax | - | - | -98,182.75* | |
| Net loss | -6,665,159 | -18,606,182 | -3,837,311.5* | |
| Less net loss attributable to noncontrolling interest | 68 | -12,619 | -47,130.5* | |
| Net loss attributable to bnb plus corp | -6,665,227 | -18,593,563 | -3,790,181* | |
| Deemed dividend related to warrant modifications | - | 32,827 | 13,581,724* | |
| Net loss attributable to common stockholders | -6,665,227 | -18,626,390 | -17,371,905 | |
| Basic EPS | -0.68 | -2.08 | -33.558 | |
| Diluted EPS | -0.68 | -2.08 | -33.558 | |
| Basic Average Shares | 9,735,631 | 8,942,937 | 517,671 | |
| Diluted Average Shares | 9,735,631 | 8,942,937 | 517,671 | |
BNB PLUS CORP. (BNBX)
BNB PLUS CORP. (BNBX)